Literature DB >> 31520104

Understanding tumor lysis syndrome.

Lara Zafrani1,2, Emmanuel Canet3, Michael Darmon4.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31520104     DOI： 10.1007/s00134-019-05768-x

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  16 in total

1.  Continuous veno-venous hemodiafiltration for the treatment of spontaneous tumor lysis syndrome complicated by acute renal failure and severe hyperuricemia.

Authors:  M Agha-Razii; S L Amyot; V Pichette; J Cardinal; D Ouimet; M Leblanc
Journal:  Clin Nephrol       Date:  2000-07       Impact factor: 0.975

Review 2.  Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus.

Authors:  Mitchell S Cairo; Bertrand Coiffier; Alfred Reiter; Anas Younes
Journal:  Br J Haematol       Date:  2010-03-16       Impact factor: 6.998

3.  Guidelines for the management of tumour lysis syndrome in adults and children with haematological malignancies on behalf of the British Committee for Standards in Haematology.

Authors:  Gail L Jones; Andrew Will; Graham H Jackson; Nicholas J A Webb; Simon Rule
Journal:  Br J Haematol       Date:  2015-04-15       Impact factor: 6.998

4.  Extreme hyperphosphataemia causing acute anuric nephrocalcinosis in lymphosarcoma.

Authors:  A Kanfer; G Richet; J Roland; F Chatelet
Journal:  Br Med J       Date:  1979-05-19

5.  Prognostic significance of acute renal injury in acute tumor lysis syndrome.

Authors:  Michael Darmon; Isabelle Guichard; François Vincent; Benoit Schlemmer; Elie Azoulay
Journal:  Leuk Lymphoma       Date:  2010-02

Review 6.  Tumour lysis syndrome: new therapeutic strategies and classification.

Authors:  Mitchell S Cairo; Michael Bishop
Journal:  Br J Haematol       Date:  2004-10       Impact factor: 6.998

7.  Tumour lysis syndrome and acute kidney injury in high-risk haematology patients in the rasburicase era. A prospective multicentre study from the Groupe de Recherche en Réanimation Respiratoire et Onco-Hématologique.

Authors:  Michael Darmon; François Vincent; Laurent Camous; Emmanuel Canet; Caroline Bonmati; Thorsten Braun; Denis Caillot; Jérôme Cornillon; Sophie Dimicoli; Anne Etienne; Lionel Galicier; Alice Garnier; Stéphane Girault; Mathilde Hunault-Berger; Jean-Pierre Marolleau; Philippe Moreau; Emmanuel Raffoux; Christian Recher; Anne Thiebaud; Catherine Thieblemont; Elie Azoulay
Journal:  Br J Haematol       Date:  2013-06-15       Impact factor: 6.998

8.  Acute renal failure caused by extreme hyperphosphatemia after chemotherapy of an acute lymphoblastic leukemia.

Authors:  J M Boles; J L Dutel; J Briere; P Mialon; M Robasckiewicz; M Garre; J Briere
Journal:  Cancer       Date:  1984-06-01       Impact factor: 6.860

9.  Pre-treatment with oral hydroxyurea prior to intensive chemotherapy improves early survival of patients with high hyperleukocytosis in acute myeloid leukemia.

Authors:  Anne-Claire Mamez; Emmanuel Raffoux; Sylvie Chevret; Virginie Lemiale; Nicolas Boissel; Emmanuel Canet; Benoît Schlemmer; Hervé Dombret; Elie Azoulay; Etienne Lengliné
Journal:  Leuk Lymphoma       Date:  2016-02-05

10.  Acute kidney injury in patients with newly diagnosed high-grade hematological malignancies: impact on remission and survival.

Authors:  Emmanuel Canet; Lara Zafrani; Jerome Lambert; Catherine Thieblemont; Lionel Galicier; David Schnell; Emmanuel Raffoux; Etienne Lengline; Sylvie Chevret; Michael Darmon; Elie Azoulay
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240
View more
  6 in total

1.  Onco-nephrology: what the intensivist needs to know.

Authors:  Mitchell H Rosner; Michael Darmon; Marlies Ostermann
Journal:  Intensive Care Med       Date:  2022-08-09       Impact factor: 41.787

2.  Risk factors of tumor lysis syndrome in relapsed/refractory multiple myeloma patients undergoing BCMA CAR-T cell therapy.

Authors:  Qiqi Zhang; Cheng Zu; Ye Meng; Yuqi Lyu; Yongxian Hu; He Huang
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2022-04-25

3.  Post-remission outcomes in AML patients with high hyperleukocytosis and inaugural life-threatening complications.

Authors:  Sofiane Fodil; Sylvie Chevret; Camille Rouzaud; Sandrine Valade; Florence Rabian; Eric Mariotte; Emmanuel Raffoux; Raphael Itzykson; Nicolas Boissel; Marie Sébert; Lionel Adès; Lara Zafrani; Elie Azoulay; Etienne Lengliné
Journal:  PLoS One       Date:  2022-07-07       Impact factor: 3.752

4.  Tumor Lysis Syndrome and AKI: Beyond Crystal Mechanisms.

Authors:  Marine Arnaud; Maud Loiselle; Camille Vaganay; Stéphanie Pons; Emmanuel Letavernier; Jordane Demonchy; Sofiane Fodil; Manal Nouacer; Sandrine Placier; Perrine Frère; Eden Arrii; Julien Lion; Nuala Mooney; Raphael Itzykson; Chakib Djediat; Alexandre Puissant; Lara Zafrani
Journal:  J Am Soc Nephrol       Date:  2022-05-06       Impact factor: 14.978

Review 5.  Management of HIV-infected patients in the intensive care unit.

Authors:  François Barbier; Mervin Mer; Piotr Szychowiak; Robert F Miller; Éric Mariotte; Lionel Galicier; Lila Bouadma; Pierre Tattevin; Élie Azoulay
Journal:  Intensive Care Med       Date:  2020-02-03       Impact factor: 17.440

6.  Fatal tumor lysis syndrome in a patient with metastatic gastric adenocarcinoma.

Authors:  Robin Moiseff; Cameron Felty; Xiaoying Liu
Journal:  Autops Case Rep       Date:  2020-12-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.